Akero Therapeutics Inc. Common Stock is a biotechnology company that focuses on developing and commercializing treatments for serious metabolic diseases. With a strong pipeline of innovative therapies, the company aims to address the unmet medical needs of patients suffering from conditions such as non-alcoholic steatohepatitis. Akero Therapeutics Inc. is committed to making a difference in the lives of patients and transforming the treatment landscape for these diseases.
Notification